Analysis of the Rehabilitation Effect of Breastfeeding Combined with Time-Sensitive Motivational Nursing Care on Neonatal Hyperbilirubinemia
Tiantian Ding Weihai Maternal and Child Health Care Hospital, Weihai Shandong 264200, China
Abstract: Objective To analyze the intervention value of breastfeeding and timely incentive nursing in patients with neonatal hyperbilirubinemia. Methods Eighty neonates with hyperbilirubinemia were selected as the research subjects. The patients were randomly grouped. The control group was given conventional care, while the observation group was given breastfeeding combined with timely incentive care. The improvement time and adverse reactions of the two groups of children were compared, and the satisfaction of family members and serum bilirubin index were investigated. Results After nursing care, the rate of disease regression in the observation group was faster than that in the control group (P< 0.05). The adverse reaction rate of children in the observation group was lower than that in the control group (P<0.05). The satisfaction rate of the observation group was higher than that of the control group (P<0.05). Before the nursing care, there was no significant difference in serum bilirubin between the groups (P>0.05). After the nursing care, the serum bilirubin in the observation group was lower than that in the control group (P<0.05). Conclusion Administering breastfeeding to neonates with hyperbilirubinemia combined with timely incentive care for the children can exert an auxiliary effect, promote the recovery of the condition and enhance the satisfaction of family members with the service, which has clinical application value. Keywords : Breastfeeding Timeliness incentive nursing Neonatal hyperbilirubinemia Satisfaction
论文收录证明 / 文献检索报告
Document Retrieval Certificate / Proof of Publication Indexing
作者贡献声明 / 贡献确认书
Author Contribution Statement / Certificate of Authorship Contribution
This article is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). For details of the license, please visit:https://creativecommons.org/licenses/by/4.0/.